1. Home
  2. MOLN vs EVC Comparison

MOLN vs EVC Comparison

Compare MOLN & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • EVC
  • Stock Information
  • Founded
  • MOLN 2004
  • EVC 1996
  • Country
  • MOLN Switzerland
  • EVC United States
  • Employees
  • MOLN N/A
  • EVC N/A
  • Industry
  • MOLN
  • EVC Broadcasting
  • Sector
  • MOLN
  • EVC Industrials
  • Exchange
  • MOLN Nasdaq
  • EVC Nasdaq
  • Market Cap
  • MOLN 183.2M
  • EVC 188.3M
  • IPO Year
  • MOLN 2021
  • EVC 2000
  • Fundamental
  • Price
  • MOLN $3.89
  • EVC $2.29
  • Analyst Decision
  • MOLN
  • EVC
  • Analyst Count
  • MOLN 0
  • EVC 0
  • Target Price
  • MOLN N/A
  • EVC N/A
  • AVG Volume (30 Days)
  • MOLN 2.5K
  • EVC 319.3K
  • Earning Date
  • MOLN 05-15-2025
  • EVC 08-07-2025
  • Dividend Yield
  • MOLN N/A
  • EVC 8.62%
  • EPS Growth
  • MOLN N/A
  • EVC N/A
  • EPS
  • MOLN N/A
  • EVC N/A
  • Revenue
  • MOLN $2,525,030.00
  • EVC $378,623,000.00
  • Revenue This Year
  • MOLN N/A
  • EVC $64.06
  • Revenue Next Year
  • MOLN $866.67
  • EVC N/A
  • P/E Ratio
  • MOLN N/A
  • EVC N/A
  • Revenue Growth
  • MOLN N/A
  • EVC 23.10
  • 52 Week Low
  • MOLN $3.36
  • EVC $1.58
  • 52 Week High
  • MOLN $12.70
  • EVC $2.73
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 49.48
  • EVC 63.27
  • Support Level
  • MOLN $3.76
  • EVC $2.03
  • Resistance Level
  • MOLN $4.13
  • EVC $2.73
  • Average True Range (ATR)
  • MOLN 0.18
  • EVC 0.14
  • MACD
  • MOLN 0.01
  • EVC 0.02
  • Stochastic Oscillator
  • MOLN 50.00
  • EVC 50.65

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: